You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API eribulin mesylate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing eribulin mesylate

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
BSP Pharmaceuticals SpA	HALAVEN	eribulin mesylate	43624-002	ALCOHOL
BSP Pharmaceuticals SpA	HALAVEN	eribulin mesylate	43624-002	WATER
Eisai Inc	HALAVEN	eribulin mesylate	62856-389	ALCOHOL
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing eribulin mesylate

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167	ALCOHOL
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167	HYDROCHLORIC ACID
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167	SODIUM HYDROXIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for eribulin mesylate

Excipient focus: ALCOHOL

eribulin mesylate drug variants containing ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167
Baxter Healthcare Corporation	eribulin mesylate	10019-080
BSP Pharmaceuticals SpA	eribulin mesylate	43624-002
>Company	>Ingredient	>NDC

eribulin mesylate drug variants not containing ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

eribulin mesylate drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167
Baxter Healthcare Corporation	eribulin mesylate	10019-080
Apotex Corp	eribulin mesylate	60505-6289
>Company	>Ingredient	>NDC

eribulin mesylate drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
BSP Pharmaceuticals SpA	eribulin mesylate	43624-002
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

eribulin mesylate drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167
Baxter Healthcare Corporation	eribulin mesylate	10019-080
Apotex Corp	eribulin mesylate	60505-6289
>Company	>Ingredient	>NDC

eribulin mesylate drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
BSP Pharmaceuticals SpA	eribulin mesylate	43624-002
>Company	>Ingredient	>NDC

Excipient focus: WATER

eribulin mesylate drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
HIKMA PHARMACEUTICALS USA INC	eribulin mesylate	0143-9167
Baxter Healthcare Corporation	eribulin mesylate	10019-080
BSP Pharmaceuticals SpA	eribulin mesylate	43624-002
>Company	>Ingredient	>NDC

eribulin mesylate drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.